Genentech, Inc. has appointed
Gary Harbour, Ph.D. to vice president, commercial quality, South San Francisco and has promoted
Robert Andreatta to controller.
Dr. Harbour will be responsible for leading the quality function in all commercial bulk, filling and packaging operations in South San Francisco. He will report to
Vince Anicetti, vice president, commercial quality. He joins the company from Pfizer, where he was senior director of global manufacturing quality operations Europe and a member of Pfizer's quality leadership team. Prior to that, Dr. Harbour held various quality and global supply vice-presidential roles with Upjohn and then Pharmacia and served on the board of directors for various international companies.
Mr. Andreatta will be responsible for accounting and reporting, financial services, collaborations finance, and tax and will report to
John Whiting, vice president, finance and chief accounting officer. Mr. Andreatta joined the company in 2003 as director, collaborations finance. He has held positions of increasing responsibility, including director, corporate accounting and reporting, and senior director, corporate finance and assistant controller. Prior to his employment with Genentech, he was chief operating officer and chief financial officer at HopeLink Corp. Prior to that, he was an audit partner with KPMG.
Magazine
